STAAR Surgical Company
STAA
$25.26
-$0.61-2.36%
NASDAQ
| 06/27/2025 | 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | |
|---|---|---|---|---|---|
| Revenue | 44.32M | 42.59M | 48.95M | 88.59M | 99.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 44.32M | 42.59M | 48.95M | 88.59M | 99.01M |
| Cost of Revenue | 11.52M | 14.58M | 17.30M | 20.10M | 20.59M |
| Gross Profit | 32.80M | 28.01M | 31.65M | 68.49M | 78.41M |
| SG&A Expenses | 47.19M | 49.02M | 47.45M | 48.24M | 54.58M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 68.98M | 77.27M | 76.80M | 82.84M | 87.04M |
| Operating Income | -24.66M | -34.68M | -27.85M | 5.75M | 11.96M |
| Income Before Tax | -25.92M | -54.49M | -30.33M | 13.16M | 10.33M |
| Income Tax Expenses | -9.10M | -275.00K | 3.89M | 3.18M | 2.96M |
| Earnings from Continuing Operations | -16.81M | -54.21M | -34.23M | 9.98M | 7.38M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.81M | -54.21M | -34.23M | 9.98M | 7.38M |
| EBIT | -24.66M | -34.68M | -27.85M | 5.75M | 11.96M |
| EBITDA | -22.68M | -32.34M | -25.47M | 7.51M | 13.49M |
| EPS Basic | -0.34 | -1.10 | -0.69 | 0.20 | 0.15 |
| Normalized Basic EPS | -0.26 | -0.40 | -0.38 | 0.17 | 0.13 |
| EPS Diluted | -0.34 | -1.10 | -0.69 | 0.20 | 0.15 |
| Normalized Diluted EPS | -0.26 | -0.40 | -0.38 | 0.17 | 0.13 |
| Average Basic Shares Outstanding | 49.52M | 49.34M | 49.27M | 49.20M | 49.13M |
| Average Diluted Shares Outstanding | 49.52M | 49.34M | 49.27M | 49.73M | 49.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |